Recruiting

CATS Tonometer Prism

Sponsor:

Intuor Technologies, Inc.

Code:

NCT04180111

Conditions

Keratoconus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

CATS Tonometer

Study Details

Brief summary:

The purpose of this study is to determine if the device, CATS tonometer prism, measures intraocular pressure significantly differently than the current standard of care tonometer prism (Goldmann) before and after a corneal crosslinking procedure. This difference would be a measurement of the amount of corneal biomechanical changes made due to the cross-linking procedure.

Conditions

Keratoconus

Study ID

NCT04180111

Start date

May 5, 2019

Status verified date

Nov, 2019

Completion date

Dec 30, 2019

Anticipated

Primary completion date

Dec 30, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Male and female patients, at least 18 years of age
  • Subject has a clear understanding and agrees to all the conditions of the informed consent form

Exclusion Criteria:

  • • Subject has undergone ocular surgery within the last 3 months

  • Uncontrolled systemic disease that in the opinion of the Investigator would put the subject's heath at risk
  • Pregnant or nursing women
  • Those who have had corneal surgery including corneal laser surgery
  • Microphthalmos
  • Buphthalmos
  • Severe Dry eyes
  • Lid squeezers - blepharospasm
  • Nystagmus
  • corneal or conjunctival infection.

Study Design

Enrollment

18 participants

Anticipated

Interventions and Outcome Measures

Interventions

CATS Tonometer

CATS Tonometer Prism

Primary outcome measure

  • IOP measurement [ Time Frame: 6 months ]

Central Contacts and Locations

Locations

Arizona Eye Consultants

Recruiting

Tucson, Arizona, United States, 85710

Contacts

More Information

Sponsor

Intuor Technologies, Inc.

Last update posted

Nov 27, 2019

Last verified

Nov, 2019

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Intuor Technologies, Inc. on 2019-11-27.